Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode
Clinical trial NCT00191997 · COMPLETED
Trial details
- NCT number
- NCT00191997
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.